Swiss Stock Exchange Spex Sw News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Swiss stock exchange spex sw. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Swiss Stock Exchange Spex Sw Today - Breaking & Trending Today

Spexis provides business update and announces financial

Spexis provides business update and announces financial results for the first half of 2023. ....

United States , Switzerland General , United Kingdom , Hernan Levett , Stephan Feldhaus , Oliver Zerbe , Stephen Jasper , Maxim Group , Trinity Hall College , University Of Oxford , American Cancer Society , Blavatnik Family Foundation , European Research Council , European Federation Of Medicinal Chemistry , University Of Zurich , European Innovative Medicines Initiative , Swiss Federal Institute Of Technology , Gilmartin Group , International Chemical Biology Society , Royal Society Of Chemistry , Jeff Wager , Orphan Drug , Science Advances , Professor Oliver Zerbe , Full Professor , Chemical Biology ,

Spexis announces USD $2.5 million capital commitment to

Ad hoc announcement pursuant to Art. 53 LR ALLSCHWIL, Switzerland, Aug. 14, 2023 (GLOBE NEWSWIRE) Spexis AG (SIX: SPEX), a clinical-stage. ....

Switzerland General , Stephan Feldhaus , Hernan Levett , Jeff Wager , Swiss Stock Exchange Spex Sw , Pexis Ag , Cystic Fibrosis , Respiratory Disease ,

Spexis reports solid safety and pharmacokinetics results

Ad hoc announcement pursuant to Art. 53 LR Inhaled murepavadin shown to be well tolerated at all dose levels Program derived from Spexis’. ....

Switzerland General , Hernan Levett , Stephan Feldhaus , Juergen Froehlich , European Innovative Medicines Initiative , Chief Medical Officer , Swiss Stock Exchange Spex Sw , Pexis Ag , Cystic Fibrosis , On Cf Bronchiectasis , Clinical Data , Phase 1 ,

Spexis announces promising pre-clinical data with

Balixafortide shown to have synergistic or additive effect with conventional or targeted therapies across all tested B-cell lymphomas ALLSCHWIL,. ....

Switzerland General , Brigitte Keller Laurie Doyle , Francesco Bertoni , Hernan Levett , Stephan Feldhaus , Juergen Froehlich , Fosun Pharma , Raimund Gabriel , Mc Services , Institute Deputy , Institute Of Oncology Research In Bellinzona , Oncology Research , Lymphoma Genomics , Institute Deputy Director , Adjunct Professor , Svizzera Italiana , Chief Medical Officer , Spexi Macrocycle Platform , Swiss Stock Exchange Spex Sw , Pexis Ag ,